Showing 241 - 255 results of 255 for search '"INKT"', query time: 0.07s Refine Results
  1. 241

    The role of natural killer T cells in atherosclerosis by Engelen, SE

    Published 2022
    “…It proposes innovative imaging modalities to study the APC-iNKT axis in the human plaque, and associates NKT plaque-abundance with clinical parameters for the first time. …”
    Thesis
  2. 242

    IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. by Paméla Gasse, Nicolas Riteau, Rachel Vacher, Marie-Laure Michel, Alain Fautrel, Franco di Padova, Lizette Fick, Sabine Charron, Vincent Lagente, Gérard Eberl, Marc Le Bert, Valérie F J Quesniaux, François Huaux, Maria Leite-de-Moraes, Bernhard Ryffel, Isabelle Couillin

    Published 2011-01-01
    “…Using FACS analysis, we show a very early IL-17A and IL-17F expression by RORγt(+) γδ T cells and to a lesser extent by CD4αβ(+) T cells, but not by iNKT cells, 24 hrs after BLM administration. Moreover, IL-23p19 and IL-17A expressions or IL-17RA signaling are necessary to pulmonary TGF-β1 production, collagen deposition and evolution to fibrosis.…”
    Get full text
    Article
  3. 243

    Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules. by Denkberg, G, Stronge, V, Zahavi, E, Pittoni, P, Oren, R, Shepherd, D, Salio, M, McCarthy, C, Illarionov, P, van der Merwe, A, Besra, G, Dellabona, P, Casorati, G, Cerundolo, V, Reiter, Y

    Published 2008
    “…The glycolipid alpha-galactosylceramide (alpha-GalCer) is a potent activator of invariant natural killer T (iNKT) cells and has been shown to be an effective agent against cancer, infections and autoimmune diseases. …”
    Journal article
  4. 244

    Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways by Sandra Domingo, Cristina Solé, Teresa Moliné, Berta Ferrer, Josefina Cortés-Hernández

    Published 2021-12-01
    “…Immune cell subset analysis in thalidomide’s CLE responder patients showed a reduction of circulating and tissue cytotoxic T-cells with an increase of iNKT cells and a shift towards a Th2 response. We conducted an RNA-sequencing study using CLE skin biopsies performing a Therapeutic Performance Mapping System (TMPS) analysis in order to generate a predictive model of its mechanism of action and to identify new potential therapeutic targets. …”
    Get full text
    Article
  5. 245

    Alterations of Specific Lymphocytic Subsets with Aging and Age-Related Metabolic and Cardiovascular Diseases by Ying Jen Chen, Yi Jen Liao, Van Thi Ngoc Tram, Chung Hao Lin, Kuo Chen Liao, Chao Lien Liu

    Published 2020-10-01
    “…The frequencies of CD3T, CD8T and invariant natural killer T (iNKT) cells were decreased in the EH, E-MD and E-CVD cohorts, indicating a decline in defense function. …”
    Get full text
    Article
  6. 246

    Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes by Ahmad Mahfuz, Gazali, Schroderus, Anna-Mari, Salonen, Kirsti Näntö, Rintamäki, Reeta, Pihlajamäki, Jussi, Knip, Mikael, Veijola, Riitta, Toppari, Jorma, Ilonen, Jorma, Kinnunen, Tuure

    Published 2020
    “…Methods We analysed the frequency, phenotype and functionality of peripheral bloodMAIT cells, as well as γδ T cells, invariant natural killer T (iNKT) cells and natural killer (NK) cells with flow cytometry in a cross-sectional paediatric cohort (aged 2–15) consisting of 51 children with newly diagnosed type 1 diabetes, 27 autoantibody-positive (AAb+) at-risk children, and 113 healthy control children of similar age and HLA class II background. …”
    Get full text
    Article
  7. 247

    Immunotherapy and immunomodulation for haematological malignancies by Mussai, F, Dr Francis Mussai

    Published 2012
    “…Finally, invariant Natural Killer T cells (iNKT) were shown to be cytotoxic to some AML blasts, in the presence of alpha Galactosylceramide, and thus able to restore T cell proliferation.…”
    Thesis
  8. 248

    Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity by Rahel Fitzel, Kathy-Ann Secker-Grob, Hildegard Keppeler, Fulya Korkmaz, Rebekka Schairer, Estelle Erkner, Dominik Schneidawind, Claudia Lengerke, Thomas Hentrich, Julia M. Schulze-Hentrich, Corina Schneidawind

    Published 2023-07-01
    “…Moreover, we found activation of T, NK and iNKT cells, release of immunomodulatory cytokines and downregulation of the PD-1/PD-L1 axis upon inhibitor treatment leading to improved cytotoxicity.In summary, the inhibition of MYC and MAT2A or PRMT5 drives robust synergistic anti-leukemic activity in MLLr leukemia. …”
    Get full text
    Article
  9. 249

    The role of DOCK8 in the maintenance of CD8+ T cell memory and invariant NKT cells by Crawford, G

    Published 2012
    “…In addition to the loss of peripheral T cells, rare populations of lymphocytes such as invariant natural killer T cells (iNKT) were also reduced in the liver and thymus. …”
    Thesis
  10. 250

    Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis by Brianne N. Sullivan, Mia A. Baggett, Christa Guillory, MaryJane Jones, Chad Steele

    Published 2022-10-01
    “…The IN + IV + steroid group demonstrated significant decreases in monocytes, eosinophils, dendritic cells (DCs), and invasive natural killer T (iNKT) cells, but not neutrophils or γδ T cells, in the brain compared to the IN + IV group. …”
    Get full text
    Article
  11. 251

    Convergence, plasticity, and tissue residence of regulatory T cell response via TCR repertoire prism by Tatyana O Nakonechnaya, Bruno Moltedo, Ekaterina V Putintseva, Sofya Leyn, Dmitry A Bolotin, Olga V Britanova, Mikhail Shugay, Dmitriy M Chudakov

    Published 2024-04-01
    “…This transition includes a dominant tumor-responding eCD4 CDR3 motif, as well as characteristic iNKT TCRα CDR3. In addition, we examine the homeostatic tissue residency of clonal eTreg populations by excluding the site of challenge from our analysis. …”
    Get full text
    Article
  12. 252

    Transmitted Fetal Immune Response in Cases of SARS-CoV-2 Infections during Pregnancy by Ernesto González-Mesa, Eduardo García-Fuentes, Rafael Carvia-Pontiasec, Ana I. Lavado-Fernández, Celia Cuenca-Marín, María Suárez-Arana, Marta Blasco-Alonso, Blanca Benítez-Lara, Laura Mozas-Benítez, Ana González-Cazorla, Herink Egeberg-Neverdal, Jesús S. Jiménez-López

    Published 2022-01-01
    “…Lymphocyte subsets were studied according to CD3, CD8, CD4, CD34, and invariant natural Killer T cells (iNKT) markers. We used in situ hybridization techniques for the detection of viral RNA in placentas. (3) Results: During the study period, 79 pregnant women and their corresponding newborns were recruited. …”
    Get full text
    Article
  13. 253

    Activation and In Vivo Evolution of the MAIT Cell Transcriptome in Mice and Humans Reveals Tissue Repair Functionality by Timothy S.C. Hinks, Emanuele Marchi, Maisha Jabeen, Moshe Olshansky, Ayako Kurioka, Troi J. Pediongco, Bronwyn S. Meehan, Lyudmila Kostenko, Stephen J. Turner, Alexandra J. Corbett, Zhenjun Chen, Paul Klenerman, James McCluskey

    Published 2019-09-01
    “…Transcriptomes of MAIT cells and H2-M3-specific CD8+ T cells displayed the most similarities to invariant natural killer T (iNKT) cells when activated, but to γδ T cells after the resolution of infection. …”
    Get full text
    Article
  14. 254

    Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design by Yan-Ruide Li, Christopher J. Ochoa, Yichen Zhu, Adam Kramer, Matthew Wilson, Ying Fang, Yuning Chen, Tanya Singh, Gabriella Di Bernardo, Enbo Zhu, Derek Lee, Neda A. Moatamed, Joanne Bando, Jin J. Zhou, Sanaz Memarzadeh, Lili Yang

    Published 2023-10-01
    “…Notably, we identified CD1d as a biomarker of the OC microenvironment and demonstrated its targeting by invariant natural killer T (iNKT) cells. Overall, our study presents a comprehensive immuno-profiling of OC tumor and microenvironment during disease progression, guiding the development of immunotherapies for OC treatment, especially for recurrent disease.…”
    Get full text
    Article
  15. 255